Cefpirome indications: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
 
Line 18: Line 18:


* Severe infections in intensive care patients
* Severe infections in intensive care patients
'''''Infections caused by the following pathogens have been successfully treated in clinical trials:'''''
======Gram-Positive Organisms======
* [[Staphylococcus aureus]] and coagulative-negative [[staphylococcus]] spp.
:* [[Staphylococcus epidermidis]]
:* [[Staphylococcus hominis]]
:* [[Staphylococcus saprophyticus]]
:* [[Staphylococcus warneri]]
* Hemolytic and non-hemolytic [[streptococci]]
* [[Streptococcus pyogenes]] (Group A)
* Streptococci of groups B and F
* [[Streptococcus pneumoniae]]
* [[Streptococcus agalactiae]]
* Streptococcus of viridans groups
* [[Enterococcus faecalis]]
* [[Corynebacterium]] spp.
======Gram-negative organisms======
* [[Escherichia coli]]
* [[Enterobacter]] spp.
* Indole-positive and indole-negative [[Klebsiella]] spp. and [[Proteus]] spp.
* [[Morganella morganii]]
* [[Providencia]] spp.
* [[Citrobacter]] spp.
* [[Salmonella]] spp.
* [[Hafnia alvei]]
* [[Serratia marcescens]]
* [[Pasteurella multocida]]
* [[Haemophilus influenzae]] and other [[Haemophilus]] species
* [[Moraxella catarrhalis]]
* [[Neisseria]] spp.
* [[Alcaligenes]] spp.
* [[Pseudomonas aeruginosa]] and other Pseudomonas species
* [[Acinetobacter calcoaceticus]]
* [[Bacteroides]] spp.
====In Vitro Sensitivity====
======Gram positive organisms======
* [[Staphylococcus aureus]]
* [[Coagulase]]-neqative Staphylococcus spp.
* [[Streptococcus]] Group A, B, C, F, and G
* [[Streptococcus mitis]]
* [[Streptococcus sanguis]]
* [[Streptococcus viridans]]
* [[Streptococcus pneumoniae]]
* [[Propionibacterium acnes]]
* [[Peptostreptococcus anaerobius]]
* [[Corynebacterium diphtheriae]]
* [[Corynebacterium pyogenes]]
======Gram-negative organisms======
* [[Citrobacter]] spp.
* [[Escherichia coli]]
* [[Salmonella]] spp.
* [[Shigella]] spp.
* [[Klebsiella]] spp.
* [[Enterobacter]] spp.
* [[Hafnia alvei]]
* [[Serratia]] spp.
* [[Proteus mirabilis]]
* [[Proteus vulgaris]]
* [[Proteus rettgeri]]
* [[Morganella morganii]]
* [[Providencia]] spp.
* [[Yersinia enterocolitica]]
* [[Pasteurella multocida]]
* [[Haemophilus influenzae]]
* [[Haemophilus ducreyi]]
* [[Moraxella catarrhalis]]
* [[Neisseria meningitidis]]
* [[Neisseria gonorrhoeae]]
* [[Aeromonas hydrophilia]]
'''''Most strains of the following species showing in vitro sensitivity'''''
======Gram-positive organisms======
* [[Enterococcus faecalis]]
* [[Clostridium]] spp.
======Gram-Negative Organisms======
* [[Pseudomonas aeruginosa]]
* [[Pseudomonas]] spp.
* [[Acinetobacter]] spp.
* [[Bacteroides fragilis]]
'''''Most strains of the following species are resistant in vitro'''''
======Gram-Positive Organisms======
* [[Staphylococcus]] spp. (methicillin-resistanl strains)
* [[Enterococcus faecium]]
* Listeria monocytogenes
* [[Clostridium difficile]]
======Gram-Negative Organisms======
* [[Xanthomonas maltophilia]]
* [[Fusobacterium varium]]
* [[Bacteroides fragilis]] (beta lactamase-producing strains)


==References==
==References==

Latest revision as of 16:17, 2 January 2014

Cefpirome
CEFROM® Package Insert
Composition
Properties
Indications
Microbiology
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Indications

Infections caused by CEFROM-sensitive organisms:[1]

  • Infections in neutropenic and immunocompromised patients
  • Skin and soft tissue infections
  • Severe infections in intensive care patients

References

  1. "http://pk.sanofi-aventis.com/products/Cefrom.pdf" (PDF). External link in |title= (help)